Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.
Get your Portfolio automatically emailed to you up to 4 times a day with Barchart Premier. FREE 30 Day Trial
Stocks | Futures | Watchlist | More
or

Evaxion Biotech A/S ADR (EVAX)

Evaxion Biotech A/S ADR (EVAX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Profile for [[ item.sessionDateDisplayLong ]]

Company Info

Evaxion Biotech A/S ADR Dr. Neergaards Vej 5F Hoersholm G7 2970 DNK

www.evaxion-biotech.com P: 45-3131-9753

Description:

Evaxion Biotech A/S is a clinical-stage biotechnology company. It involved in the development of AI-driven immunotherapies for patients with cancer and infectious diseases. Evaxion Biotech A/S is based in COPENHAGEN, Denmark.

Key Statistics

Overview:

Market Capitalization, $K 21,538
Enterprise Value, $K 24,608
Shares Outstanding, K 5,215
Annual Sales, $ 70 K
Annual Net Income, $ -22,130 K
Last Quarter Sales, $ 70 K
Last Quarter Net Income, $ -4,520 K
EBIT, $ -22,190 K
EBITDA, $ -21,570 K
60-Month Beta -0.02
% of Insider Shareholders 41.64%
% of Institutional Shareholders 11.04%
Float, K 3,044
% Float 58.36%
Short Volume Ratio 0.20

Growth:

1-Year Return -70.61%
3-Year Return -94.21%
5-Year Return 0.00%
5-Year Revenue Growth 0.00%
5-Year Earnings Growth 0.00%
5-Year Dividend Growth 0.00%

Per-Share Information:

Most Recent Earnings -0.16 on 03/27/24
Latest Earnings Date 05/29/24
Earnings Per Share ttm -6.76
EPS Growth vs. Prev Qtr 92.38%
EPS Growth vs. Prev Year 94.48%
Annual Dividend Yield 0.00%
Dividend Payout Ratio 0.00%
Most Recent Split 1-10 on 01/22/24

EVAX Ratios

Ratio
Price/Earnings ttm 0.00
Price/Earnings forward N/A
Price/Earnings to Growth N/A
Return-on-Equity % 0.00%
Return-on-Assets % -149.27%
Profit Margin % -31,614.28%
Debt/Equity -1.83
Price/Sales 295.76
Price/Cash Flow N/A
Price/Book N/A
Book Value/Share -1.17
Interest Coverage -12.64
Want to use this as
your default charts setting?
Save this setup as a Chart Templates
Switch the Market flag
for targeted data from your country of choice.
Open the menu and switch the
Market flag for targeted data from your country of choice.
Want Streaming Chart Updates?
Switch your Site Preferences
to use Interactive Charts
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.

Free Barchart Webinar